Thursday, March 05, 2026 7:24:16 PM
iNBS share price wrestling with its short term moving average line.
The MA line has a slight negative trend to it, the share price appears to be
trying to hold this level. Sets up a confrontation to see if the share price can
resist the pressure of the MA line trying to 'push it lower'. If it does?
Then the MA line shifts into a 'support role' as it tends to slowly roll from negative
to neutral. WHich helps 'carry' the share price hopefully higher the longer the share price
can stay above the MA line.
Or at least that is what I am used to seeing in a 'bottoming' pattern. If it doesn't push back over
because of 'support' for the shares? Well, who knows how low it could go next.
Good luck
The MA line has a slight negative trend to it, the share price appears to be
trying to hold this level. Sets up a confrontation to see if the share price can
resist the pressure of the MA line trying to 'push it lower'. If it does?
Then the MA line shifts into a 'support role' as it tends to slowly roll from negative
to neutral. WHich helps 'carry' the share price hopefully higher the longer the share price
can stay above the MA line.
Or at least that is what I am used to seeing in a 'bottoming' pattern. If it doesn't push back over
because of 'support' for the shares? Well, who knows how low it could go next.
Good luck
Recent INBS News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 03:24:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 12:30:46 PM
- Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year • GlobeNewswire Inc. • 05/13/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 12:00:55 PM
- Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified • GlobeNewswire Inc. • 04/17/2026 12:30:00 PM
- Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market • GlobeNewswire Inc. • 04/02/2026 12:30:00 PM
- Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 08:30:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/23/2026 08:10:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:26 PM
- Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry • GlobeNewswire Inc. • 02/25/2026 01:45:00 PM
- Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout • GlobeNewswire Inc. • 02/24/2026 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 01:55:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 01:31:15 PM
- Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year • GlobeNewswire Inc. • 02/12/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 01:53:26 PM
- Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year • GlobeNewswire Inc. • 02/05/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 10:15:25 PM
- Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
